A computational screen of 160,000 tetrapeptides revealed that tryptophan-rich sequences are the most potent food-derived ACE inhibitors, with top candidates rivaling pharmaceutical potency in lab tests.
160,000 peptides screenedEvery possible four-amino-acid combination was computationally tested against ACE, revealing tryptophan as the single most important amino acid for inhibitory activity.
What the researchers found
By computationally screening 160,000 possible four-amino-acid peptides against ACE (the enzyme targeted by blood pressure drugs like lisinopril), researchers identified the amino acid characteristics that make a peptide a strong ACE inhibitor. Tryptophan (Trp) was the most important amino acid, followed by tyrosine, phenylalanine, histidine, and arginine.
The top-performing tetrapeptides (WWNW, WRQF, WFRV, etc.) had IC50 values between 19.98 and 36.76 μM — potent for food-derived peptides. The binding was driven by salt bridges, π-π stacking, π-cation interactions, and hydrogen bonds. In a striking proof of concept, inserting eight tryptophan residues into rabbit skeletal muscle protein (which naturally has no tryptophan) gave it over 90% ACE inhibition, suggesting that tryptophan-rich meat proteins could have blood pressure benefits.
Why it matters
ACE inhibitor drugs are among the most prescribed medications worldwide for hypertension. Food-derived ACE-inhibitory peptides offer a natural, lower-side-effect alternative, but finding effective sequences has been largely trial and error. This systematic computational approach screens the entire tetrapeptide space at once, revealing clear design rules (tryptophan is king) that could accelerate discovery of functional food peptides for blood pressure management.
The numbers in context
160,000 tetrapeptides screened · Top IC50: 19.98 ± 8.19 μM · Tryptophan = most important amino acid · >90% ACE inhibition with Trp-enriched protein · 6 top peptides identified
How the study worked
Computational molecular docking of all 160,000 possible tetrapeptide combinations against the ACE enzyme structure. Top candidates were validated with in vitro ACE inhibition assays (IC50 measurements). Molecular interaction analysis identified the chemical bonds driving inhibition. A proof-of-concept experiment introduced tryptophan residues into a naturally tryptophan-free protein to test the predictive power of the findings.
Who was studied
Computational study with in vitro validation (no human or animal subjects)
What this study cannot tell us
Molecular docking is a computational prediction — actual biological activity can differ. The IC50 values are from in vitro enzyme assays, not from human blood pressure studies. Bioavailability (whether these peptides survive digestion and reach the bloodstream intact) was not tested. The 90% ACE inhibition from engineered protein was in vitro, not in an animal or human model.
How to read the evidence
This is a computational study with in vitro validation. While the screening approach is comprehensive and the IC50 data are promising, no animal or human blood pressure data are presented, placing this at the preliminary evidence stage.
When this study was published
Published in 2023. The computational screening approach is current, and the identified peptide sequences remain relevant for ongoing functional food research.
The bigger picture
This study represents the growing intersection of computational biology and functional food science. Rather than randomly testing food-derived peptides, researchers can now predict which sequences will be most active. The strong role of tryptophan could influence how food scientists design functional foods and supplements targeting blood pressure — and may partly explain why certain protein-rich diets are associated with cardiovascular benefits.
Questions still open
- Would these tryptophan-rich peptides survive human digestion and reach the bloodstream in active form?
- How do the most potent tetrapeptides compare to pharmaceutical ACE inhibitors like lisinopril in animal blood pressure models?
- Could tryptophan-enriched food proteins become a practical dietary intervention for mild hypertension?
Common questions
What are ACE inhibitory peptides and how do they relate to blood pressure drugs?
Does eating tryptophan-rich foods lower blood pressure?
Read the original research
Revealing the Sequence Characteristics and Molecular Mechanisms of ACE Inhibitory Peptides by Comprehensive Characterization of 160,000 Tetrapeptides.
Foods (Basel, Switzerland), 12(8)
Citation
Ma, Mingzhe; Feng, Yinghui; Miao, Yulu; Shen, Qiang; Tang, Shuting; Dong, Juan; Zhang, John Z H; Zhang, Lujia. (2023). Revealing the Sequence Characteristics and Molecular Mechanisms of ACE Inhibitory Peptides by Comprehensive Characterization of 160,000 Tetrapeptides.. Foods (Basel, Switzerland), 12(8). https://doi.org/10.3390/foods12081573